重新定义慢性山病:来自高海拔研究和临床经验的见解
1Pulmonary, High Altitude Pulmonary and Pathology Institute, La Paz, Bolivia.
Medical review (2021)
|February 20, 2025
概括
慢性山病 (CMS) 被重新定义为多红细胞血症 (PEH),这是高海拔人口中氧气运输改变的迹象. 这一转变强调了准确的诊断和高度特定的规范,以更好地管理患者.
科学领域:
- 生理学 生理学 生理学
- 高度医学 高度医学
- 血液学 血液学 血液学
背景情况:
- 慢性山病 (CMS) 传统上与慢性低氧和红细胞增加有关.
- 最近的研究和临床经验需要重新评估CMS的定义和潜在机制.
- 高海拔地区的人口面临着独特的生理挑战,因为长时间暴露在低氧水平下.
研究的目的:
- 提出理解CMS的范式转变,将其重新定义为多红细胞血症 (PEH).
- 要强调增加的血红素/血红蛋白/红细胞 (Ht/Hb/RBCs) 是一种迹象,而不是一种疾病,反映了各种氧气运输变化.
- 倡导高度特定的血液参数规范和准确的病因学诊断,以有效管理.
主要方法:
- 在玻利维亚的高海拔肺部和病理学研究所 (HAPPI-IPPA) 审查了超过五十年的临床经验和研究成果.
- 分析慢性低血压缺氧在改变氧气运输机制中的作用.
- 强调在高海拔环境中血红细胞数量升高的患者的差异诊断.
主要成果:
- 建议将CMS重新分类为多红细胞血 (PEH),代表了一系列的氧气运输问题.
- 高海拔地区居民的Ht/Hb/RBC升高被解释为生理征兆,而不是一个独特的疾病实体.
- 这项研究强调了需要个性化,高度调整的正常血液参数范围的需要.
结论:
- 将CMS重新归类为PEH有助于更准确地了解慢性缺氧中的氧气运输.
- 建立高度特定的血液规范对于正确诊断和管理高海拔相关疾病至关重要.
- 这份更新的视角提供了对慢性低血症患者管理的见解,并告知了包括COVID-19后恢复在内的更广泛的健康挑战.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Acute Respiratory Failure-III
152
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
152
COPD: Pathogenesis and Clinical Features
226
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
226
Acute Respiratory Failure-IV
118
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
118
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


